11,313
edits
Changes
Jump to navigation
Jump to search
SW: →Safety Testing of AquAdvantage Salmon: add chem/hem tests
==== FDA Conclusion ====
Based on these studies, the FDA concludes: "AquAdvantage Salmon show no demonstrable differences from the comparator fish population when reared under growth conditions in <nowiki>[AquaBounty's Prince Edward Island]</nowiki> facility." The FDA does note that AquaBounty's culling practices may result in problems once the GE fish are marketed commercially. However, they propose to merely monitor data of abnormalities once the GE fish are already commercialized, which Michael Hansen points out is shutting the barn door after the horse runs out.<ref>Jill Richardson, Phone interview with Michael Hansen, September 7, 2010.</ref>
=== Chemistry and Hematology Testing ===
Chemistry and hematology testing was performed on the GE salmon and then compared with results of tests performed on non-GE salmon. The tests looked at the following: hemoglobin, hematocrit, platelet count, neutrophils, lymphocytes, monocytes, glucose, sodium, potassium, chloride, alanine aminotransferase, aspartate aminotransferase, total bilirubin, creatine kinase, total protein, albumin, globulin, albumin/globulin ratio, calcium, inorganic phosphorus, cholesterol, and osmolality. No data tables were provided to allow any independent assessing of the results.
==== FDA Conclusion ====
The FDA concluded as follows: "We found no clinically relevant differences in the serum chemistry or hematology values for AquAdvantage Salmon compared with contemporaneous non-GE Atlantic salmon that are clearly attributable to the GE construct."
=== Allergenicity ===
